Contraception
Supplements
Federal Health Care Data Trends 2024
Latest News
FDA mandates five changes to iPLEDGE program for isotretinoin
The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
Latest News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
Supplements
Federal Health Care Data Trends 2023
Latest News
Piroxicam boosts success of levonorgestrel for emergency contraception
Oral levonorgestrel plus oral piroxicam prevented 30% more pregnancies than levonorgestrel alone.
Conference Coverage
Youth-led sexual health program improves teen knowledge, autonomy
Participants in the 9-month program improved in all domains assessed, including sexual and reproductive health knowledge, self-efficacy and...
Conference Coverage
Scheduled bleeding may boost tolerability of hormone implants
Rates of early discontinuation have been variable, according to published literature, ranging from 13% to 21.1%, said Dr. Jordan Gray.
News
Cycle timing may reduce hormonal dosage for contraception
A mathematical model showed lower levels of hormones effectively provide contraception in the follicular phase.
News
Adherence to oral contraceptive protocols prevents pregnancy
Pregnancy rates rise when oral contraceptive users miss more than two pills or fail to follow instructions.
Latest News
Frustration over iPLEDGE evident at FDA meeting
Dermatologists argue the iPLEDGE REMS burden is too high for providers and patients. Access problems persist with lockouts and some cite a lack of...